JANX
Janux Therapeutics Inc
NASDAQ · Biotechnology
$13.07
+0.89 (+7.31%)
Open$12.45
Previous Close$12.18
Day High$13.38
Day Low$12.42
52W High$44.83
52W Low$12.12
Volume—
Avg Volume1.46M
Market Cap786.13M
P/E Ratio—
EPS$-1.68
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+275.7% upside
Current
$13.07
$13.07
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 11.85M | 8.30M | 133.28M |
| Net Income | -77,205,731 | -48,676,117 | 15.76M |
| Profit Margin | -651.6% | -619.0% | 11.8% |
| EBITDA | -108,302,149 | -72,074,985 | 19.77M |
| Free Cash Flow | — | — | 15.72M |
| Rev Growth | +42.8% | +42.8% | +7.4% |
| Debt/Equity | — | — | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |